Categories
Cohance Lifesciences Limited — Board Meeting, 27-04-2026: Outcome of Board Meeting
27-04-2026 · 08:59 am
Cohance Lifesciences' board noted Chairman Vivek Sharma's resignation (transitioning to Special Advisor). Umang Vohra steps in as new Chairman & Group CEO from May. Board also approved a 6.25% diluted equity ESOP 2026 (min. INR 325/share exercise price). Shareholder approval pending for appointments & ESOP.
No comments yet. Be the first to comment!